Free Trial
NASDAQ:LSB

Lakeshore Biopharma (LSB) Stock Price, News & Analysis

Lakeshore Biopharma logo
$1.00 +0.00 (+0.10%)
Closing price 06/6/2025 03:59 PM Eastern
Extended Trading
$0.97 -0.03 (-2.70%)
As of 06/6/2025 04:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Lakeshore Biopharma Stock (NASDAQ:LSB)

Key Stats

Today's Range
$0.95
$1.00
50-Day Range
$1.00
$2.32
52-Week Range
$0.91
$8.60
Volume
89,082 shs
Average Volume
20,716 shs
Market Capitalization
$9.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

LakeShore Biopharma Co., Ltd. engages in the provision of discovering, developing, manufacturing, and commercializing vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on developing PIKA technology platform. It operates through the People's Republic of China and Other Countries or Regions. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in Beijing, China.

Receive LSB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lakeshore Biopharma and its competitors with MarketBeat's FREE daily newsletter.

LSB Stock News Headlines

White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
LakeShore Biopharma’s Financial Leap and Rabies Vaccine Trial Approval
See More Headlines

LSB Stock Analysis - Frequently Asked Questions

Lakeshore Biopharma's stock was trading at $3.46 at the beginning of the year. Since then, LSB stock has decreased by 71.1% and is now trading at $1.00.
View the best growth stocks for 2025 here
.

Lakeshore Biopharma's stock reverse split on the morning of Friday, October 4th 2024. The 1-10 reverse split was announced on Friday, September 27th 2024. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of LSB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Lakeshore Biopharma investors own include Jiuzi (JZXN), Aethlon Medical (AEMD), Aditxt (ADTX), Adial Pharmaceuticals (ADIL), Avalon GloboCare (ALBT), Ainos (AIMD) and AMC Entertainment (AMC).

Company Calendar

Today
6/07/2025
Next Earnings (Estimated)
8/18/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:LSB
Previous Symbol
NASDAQ:LSB
Web
N/A
Fax
N/A
Employees
773
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$672.27 million
Price / Cash Flow
N/A
Book Value
$8.86 per share
Price / Book
0.11

Miscellaneous

Free Float
N/A
Market Cap
$9.31 million
Optionable
N/A
Beta
0.59
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:LSB) was last updated on 6/7/2025 by MarketBeat.com Staff
From Our Partners